Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RC3
(neurogranin) is a neuron-specific substrate of
protein kinase C
(
PKC
) that accumulates predominantly in dendritic spines of forebrain neurons and undergoes long-term potentiation (LTP)-associated increases in
PKC
-phosphorylation in hippocampal slices. Here the hypothesis that
RC3
functions by modulating the IP3/DAG second messenger pathway after its phosphorylation by DAG-activated
PKC
was tested by heterologous expression in Xenopus oocytes. Acetylcholine-evoked inward chloride (Cl-) currents, dependent on both IP3 release and intracellular calcium (Ca2+), were 2- to 3-fold higher in
RC3
-injected oocytes than in uninjected control oocytes.
RC3
-oocytes did not exhibit enhanced currents when preincubated with the protein kinase inhibitor H-7 or when a glycine residue was substituted for serine, the
PKC
phosphorylation site of
RC3
. Activation of endogenous oocyte
PKC
by phorbol esters generated inward Cl- currents in
RC3
oocytes but not in control oocytes.
RC3
-dependent Cl- currents were also elicited by phorbol ester in Ca(2+)-free media. We propose that
PKC
-phosphorylated
RC3
is capable of enhancing the mobilization of intracellular Ca2+ in Xenopus oocytes and, by inference, may play a role in Ca2+ homeostasis in dendrites of forebrain neurons.
...
PMID:Functional consequences of expression of the neuron-specific, protein kinase C substrate RC3 (neurogranin) in Xenopus oocytes. 829 95
The neuronal protein neurogranin, also known as
RC3
, is a selective substrate for
protein kinase C
(
PKC
). We synthesized a peptide corresponding to the phosphorylation domain of neurogranin (amino acids 28-43) and characterized its properties as a
PKC
substrate. Neurogranin(28-43) was phosphorylated by purified
PKC
with a Km of 150 nM. No significant phosphorylation of the peptide by either cAMP-dependent protein kinase or by calcium/calmodulin-dependent protein kinase II could be detected. Thus, neurogranin(28-43) is a potent and selective substrate for
PKC
. We tested several peptide analogues of neurogranin(28-43) for their substrate potency and specificity as kinase substrates, in order to help elucidate the structural determinants involved in the phosphorylation of substrates by
PKC
. Substituting Arg36 with Ile caused a significant reduction in the affinity for
PKC
. Replacing Lys30 with Arg enhanced the catalytic efficiency (Vmax/Km) for
PKC
but diminished the selectivity of the substrate for
PKC
. These results support the generally held model that basic amino acids on both sides of the phosphorylated Ser are important structural determinants in
PKC
substrates. However, the data also suggest that the presence of particular basic amino acids (Arg vs Lys) can contribute to the degree of selectivity of a substrate for
PKC
. Replacement with Ala of Phe35, the amino acid adjacent to the Ser34 phosphorylation site, resulted in a peptide with greatly diminished potency as a
PKC
substrate. This finding indicates a critical role of Phe35 in modulating binding and phosphorylation of neurogranin-derived peptides by
PKC
.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C. 842 32
Unbridled increases in intracellular ionized calcium can result in neuronal damage and death. Since many of the deleterious effects of calcium are mediated by calmodulin, we have sought to identify neuronal proteins that inhibit activation of this ubiquitous protein. PEP-19 is a 7.6-kDa neuron-specific protein, which contains a motif similar to the calmodulin binding domains of neuromodulin (GAP-43) and neurogranin (
RC3
). Here we show that PEP-19 binds calmodulin in an analogous calcium-independent manner with an apparent Kd near 1.2 microM. Furthermore, using the calmodulin-dependent enzyme neuronal nitric oxide synthase, we demonstrate that native PEP-19 is also an antagonist of enzyme activity. Based on the PEP-19 sequence, a series of peptide calmodulin antagonists termed camstatins were synthesized. These analogs define the minimally active domain of PEP-19 and provide a structure/activity relationship for calmodulin antagonism. There was a positive correlation between the binding affinities of the camstatins for calmodulin and their potencies as neuronal nitric oxide synthase inhibitors. Despite the similar IQ motif in PEP-19 and neuromodulin or neurogranin, PEP-19 was not a substrate for
protein kinase C
. The properties of PEP-19 suggest that it could fulfill a role in neuroprotection.
...
PMID:Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. 866 25
By using the human fetal brain library, a 1.2-kb cDNA coding for human neurogranin, a neurospecific endogenous substrate of
protein kinase C
, was cloned. The results of the Northern blot analysis of the human brain cortex mRNA show that the human neurogranin mRNA exists as a single transcript. Its gene thereby differs from the rat neurogranin gene (
RC3
), which was shown to produce two mRNAs of different lengths. cDNAs of the human and rat neurogranins show a 70% homology, whereas the protein sequences only differ in three amino acid residues out of the total of 78. The 3'-untranslated region of the human neurogranin cDNA lacks the purine-rich stretch characteristic of the rat neurogranin cDNA.
...
PMID:[Cloning cDNA for human neurogranin]. 892 22
Single-site variants in the calmodulin-binding domain of
RC3
/neurogranin were heterologously expressed in Xenopus oocytes to examine their effects on serotonin-evoked currents.
RC3
variants serine36 -->alanine (Ser36-->Ala), serine36-->glycine (Ser36-->Gly), and phenylalanine37-->tryptophan (Phe37-->Trp), which bind calmodulin but are deficient in
protein kinase C
(
PKC
) phosphorylation, display serotonin-evoked Ca(2+)-dependent Cl- currents in oocytes similar to control oocytes. A serine36-->aspartate (Ser36-->Asp) variant, which does not bind calmodulin and mimics the
PKC
-phosphorylated state of
RC3
, significantly enhances serotonin-evoked currents in a manner similar to wild-type. The results suggest that
RC3
not only regulates the availability of free calmodulin in a dendritic spine but also, when phosphorylated, independently stimulates G-protein coupled second messenger pathways that generate inositol 1,4,5-trisphosphate (IP3), diacylglycerol (DAG) and intracellular Ca2+.
...
PMID:Functional studies of single-site variants in the calmodulin-binding domain of RC3/neurogranin in Xenopus oocytes. 897 10
Long-term potentiation (LTP) is a sustained strengthening of synaptic connections that occurs in the mammalian hippocampus, and is a cellular mechanism likely to contribute to memory formation. One question of current interest is whether the biochemical mechanisms responsible for the maintenance of LTP have a presynaptic or postsynaptic locus. We have determined that the phosphorylation of the postsynaptic protein kinase (
PKC
) substrate
RC3
/neurogranin is increased in the maintenance phase of LTP, and that the induction of this effect is dependent on activation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. The sustained increase in
RC3
/neurogranin phosphorylation requires ongoing protein kinase activity, as application of the protein kinase inhibitor H-7 after LTP induction can reverse the increased
RC3
/neurogranin phosphorylation. Overall, these data are evidence for postsynaptic biochemical changes in the maintenance of LTP. They also implicate
RC3
/neurogranin as a downstream effector of
PKC
activity in LTP that could contribute to physiologic expression of LTP.
...
PMID:Enhanced phosphorylation of the postsynaptic protein kinase C substrate RC3/neurogranin during long-term potentiation. 913 17
1. Long-term potentiation and its counterpart long-term depression are two forms of activity dependent synaptic plasticity, in which protein kinases and protein phosphatases are essential. 2. B-50/GAP-43 and
RC3
/neurogranin are two defined neuronal
PKC
substrates with different synaptic localization. B-50/GAP-43 is a presynaptic protein and
RC3
/neurogranin is only found at the postsynaptic site. Measuring their phosphorylation state in hippocampal slices, allows us to simultaneously monitor changes in pre- and postsynaptic
PKC
mediated phosphorylation. 3. Induction of LTP in the CA1 field of the hippocampus is accompanied with an increase in the in situ phosphorylation of both B-50/GAP-43 and
RC3
/neurogranin, during narrow, partially overlapping, time windows. 4. Pharmacological data show that mGluR stimulation results in an increase in the in situ phosphorylation of B-50/GAP-43 and
RC3
/neurogranin.
...
PMID:Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. 915 64
High mobility group protein I (HMG-I) is a nonhistone chromosomal protein. The present study aims to examine phosphorylation of HMG-I by
protein kinase C
(
PKC
) and its effect on HMG-I's DNA binding activity. HMG-I, extracted and purified from rat brain was phosphorylated in vitro equally well by
PKC
alpha, beta, gamma and delta. Phosphoamino acid analysis indicated that both serine and threonine residues were phosphorylated. The nonphosphorylated HMG-I was shown to bind specifically to the fragment of DNA containing bp -708 to -458 of
RC3
genomic DNA, which is abundant in A-T sequences. In contrast, phosphorylation of HMG-I by
PKC
resulted in an attenuation of binding to the DNA fragment. It is suggested that phosphorylation of HMG-I by
PKC
may regulate DNA binding activity of HMG-I, thereby possibly altering its biological functions.
...
PMID:[Effect of phosphorylation by protein kinase C on the DNA binding activity of high mobility group protein I]. 920 93
RC3
/neurogranin is a postsynaptic
protein kinase C
(
PKC
)-/calmodulin-binding substrate implicated in long-term potentiation (LTP) forms of synaptic plasticity. Our previous digoxigenin in situ hybridization (DIG-ISH) studies detected
RC3
mRNA in apical dendrites and cell bodies of neurons in the rat cerebral cortex and hippocampus. This observation suggested that
RC3
mRNA is selectively translocated to dendrites, where it may be translated locally in response to synaptic activity. To test this hypothesis further, we isolated a full-length cDNA clone of the homologous human
RC3
mRNA from a human cortex lambda GT11 library, determined its nucleotide and predicted amino acid sequences, and performed mRNA expression studies in cerebral cortex from normal human patients and from patients with Alzheimer disease (AD) and fronto-temporal dementia (FTD). The human cDNA clone detects a single approximately 1.3 kb mRNA whose nucleotide sequence is 73% similar to the rat nucleotide sequence and 96% similar to its amino acid sequence. DIG-ISH studies detect robust staining of
RC3
mRNA in cell bodies of numerous neurons throughout Layers II-VI and in both apical and basal dendrites of pyramidal neurons in human neocortex (temporal/frontal). We conclude that dendritic targeting of
RC3
mRNA is conserved in human brain. In AD neocortex tissue, there is little or no evidence for
RC3
mRNA translocation to dendrites, while in FTD neocortex, targeting of
RC3
mRNA to apical dendrites is preserved. Comparative studies in AD and FTD point to the potential importance of synapse integrity and the dendritic cytoskeleton in
RC3
mRNA targeting in the human neocortex.
...
PMID:Dendritic translocation of RC3/neurogranin mRNA in normal aging, Alzheimer disease and fronto-temporal dementia. 932 54
In this review, we attempt to cover the descriptive, biochemical and molecular biological work that has contributed to our current knowledge about
RC3
/neurogranin function and its role in dendritic spine development, long-term potentiation, long-term depression, learning, and memory. Based on the data reviewed here, we propose that
RC3
, GAP-43, and the small cerebellum-enriched peptide, PEP-19, belong to a protein family that we have named the calpacitins. Membership in this family is based on sequence homology and, we believe, a common biochemical function. We propose a model wherein
RC3
and GAP-43 regulate calmodulin availability in dendritic spines and axons, respectively, and calmodulin regulates their ability to amplify the mobilization of Ca2+ in response to metabotropic glutamate receptor stimulation. PEP-19 may serve a similar function in the cerebellum, although biochemical characterization of this molecule has lagged behind that of
RC3
and GAP-43. We suggest that these molecules release CaM rapidly in response to large influxes of Ca2+ and slowly in response to small increases. This nonlinear response is analogous to the behavior of a capacitor, hence the name calpacitin. Since CaM regulates the ability of
RC3
to amplify the effects of metabotropic glutamate receptor agonists, this activity must, necessarily, exhibit nonlinear kinetics as well. The capacitance of the system is regulated by phosphorylation by
protein kinase C
, which abrogates interactions between calmodulin and
RC3
or GAP-43. We further propose that the ratio of phosphorylated to unphosphorylated
RC3
determines the sliding LTP/LTD threshold in concept with Ca2+/ calmodulin-dependent kinase II. Finally, we suggest that the close association between
RC3
and a subset of mitochondria serves to couple energy production with the synthetic events that accompany dendritic spine development and remodeling.
...
PMID:RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. 939 8
<< Previous
1
2
3
4
Next >>